维普期刊资源整合服务平台（V6.5）

168篇 您的检索式：作者名="Hillan"

选中清除导出查看参考文献查看引证文献引用追踪共9页首页上一页第1页下一页末页 /9 跳转

	题名	作者	年代	出处	被引量
1	Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer 显示文摘	Ferrara N Hillan K J Gerber HP	2004	Nat Rev Drug Discov2004，3，5：	1
2	Discovery and outcome of bevacizumab,an anti-VEGF antibody for treating cancer显示文摘	Hillan K Gerber H	2004	Nat Rev Drug Discov2004，3，5：	1
3	Importance of VEGF for breast cancer angiogenesis in vivo: implications from intravital microscopy of combination treatments with an antiVEGF neutralizing monoclonal antibody and doxorubicin 显示文摘	Borgstrom P Gold DP Hillan KJ	1999	Anticancer Res1999，19，5：	1
4	Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer显示文摘	Ferrara N Hillan K J Gerber HP Novotny W	2004	Nat Rev Drug Discov2004，3，5：	1
5	VEGF is required for growth and survival in neonatal mice显示文摘	Gerber H P Hillan K J Ryan A M	1999	Development1999，126，6：	1
6	Bevacizumab(avastin),a humanized anti-VEGF monoclonal antibody for cancer therapy显示文摘	Ferrara N Hillan KJ Novotny W	2005	Biochem Biophys Res Commun2005，333，2：	1
7	Bevaeizumab ( Avastin ) , a humanized anti-VEGF monoclonal antibody for cancer therapy 显示文摘	Ferrara N Hillan KJ Novotny W	2005	Biochem Biophys Res Commun2005，333，：	1
8	Expression of HIF-1 in human tumours显示文摘	Jubb A Hillan K	2005	J Clin Pathol2005，58，12：	1
9	Discovery and development of bevacizumab,an anti-VEGF antibody for treating cancer 显示文摘	Ferrara N Hillan KJ Gerber HP et d	2004	Nat Rev Drug Discov2004，3，：	1
10	Discovery and development of bevacizumab,an anti-VEGF antibody for treating cancer显示文摘	Ferrara N Hillan KJ Gerber HP Novotny W	2004	Nat Rev Drug Discov2004，3，：	1
11	VEGF is required for growth and survival in neonatal mice显示文摘	GERBER H P HILLAN K J RYAN A M	1999	Development1999，126，6：	1
12	Importance of VEGF for breast- cancer angiogenesis in vivo: implications from intravita\| microscopy of combinationtreatments with an anti-VEGF neutralizing monoclonal anti- body and doxorubicin 显示文摘	Borgstrom P Gold DP Hillan K J	1999	Anticancer Res1999，19，：	1
13	VEGF is required for growth and survival in neonatal mice显示文摘	Gerber HP Hillan K J Ryan AM	1999	Development1999，126，6：	1
14	The healing of colonic anastomoses after early intraperitoneal chemotherapy:an experimental study in rats显示文摘	Hillan K Nordlinger B Ballet F	1988	J Surg Res1988，44，2：	1
15	VEGF is required for growth and survival in neonatal mice显示文摘	Gerber HP Hillan K Ryan A	1999	Development1999，126，6：	1
16	Application of cDNA microarrays in determining molecular phenotype in cardiac growth,development and response to injury显示文摘	Sehl P D Tai J T Hillan K J	2000	Circulation2000，101，：	1
17	Expression of HIF - 1 alpha in human tumours显示文摘	Jubb A Hillan K	2005	J Clin Pathol2005，58，12：	1
18	Expression profiling the human septin gene family显示文摘	Hall PA lung K Hillan KJ	2005	1 Pathol2005，206，3：	1
19	Tissue microar rays in drug discovery 显示文摘	SAUTER G SIMON R HILLAN K	2003	Nat Rev Drug Discov2003，2，：	1
20	Bevacizumab (Avastin), a human- ized anti-VEGF monoclonal antibody for cancer therapy显示文摘	Ferrara N Hillan K J Nowotny W	2005	Biochem Biophys Res Commun2005，333，2：	1

返回顶部每页显示：

共9页首页上一页第1页下一页末页 /9 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示